Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 199 clinical trials
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer

-fluorouracil, and leucovorin for patients with advanced or metastatic biliary tract cancer after progression on first-line systemic therapy.

cholangiocarcinoma
leucovorin
advanced biliary tract carcinoma
fluorouracil
ffpe
  • 10 views
  • 10 Feb, 2021
  • 6 locations
A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

patients with unresectable or metastatic biliary tract cancer (BTC). About 298 subjects are randomly assigned to two study treatment groups in the ratio of 1:1 by Interactive Web Response System (IWRS

cholangiocarcinoma
surufatinib
capecitabine
adjuvant chemotherapy
intrahepatic bile duct carcinoma
  • 9 views
  • 23 Jan, 2021
  • 1 location
A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

It is a trial to compare the efficacy and safety of Nab-paclitaxel plus Cisplatin vs Gemcitabine plus Cispatin as first line chemotherapy in advanced biliary tract cancer.

  • 0 views
  • 28 Jan, 2021
  • 1 location
A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer

Target population: patients with advanced biliary tract cancer (including gallbladder carcinoma, intrahepatic and extrahepatic cholangiocarcinoma) . Primary objective

  • 0 views
  • 22 Jan, 2021
  • 1 location
DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer

To assess the effect of AZD6738 and Durvalumab combination or AZD6738 and Olaparib combination in biliary tract cancer patients who have failed to 1st-line chemotherapy.

blood transfusion
platelet count
serum bilirubin
gallbladder cancer
cancer
  • 0 views
  • 24 Jan, 2021
  • 1 location
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer

Considering that the poor prognosis of resected biliary tract cancer and negative impact on the survival outcomes of R1/R2 resection, neoadjuvant chemotherapy may improve R0 resection rates and

metastasis
cholangiocarcinoma
cisplatin/gemcitabine
durvalumab
gemcitabine
  • 0 views
  • 25 Jan, 2021
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

To evaluate the following items in patients with locally advanced and metastatic biliary tract cancer receiving SLOG or GC treatment, Primary objective: 6-month progression-free survival rate

platelet count
cancer
metastatic biliary tract carcinoma
tegafur
obstruction
  • 5 views
  • 25 Jan, 2021
  • 1 location
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

This research study is studying a combination of drugs as a possible treatment for Hepatocellular Carcinoma or Biliary Tract Cancer. The interventions involved in this study are:

metastasis
cholangiocarcinoma
tremelimumab
platelet count
durvalumab
  • 23 views
  • 02 May, 2021
  • 1 location
Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC)

international normalized ratio
cholangiocarcinoma
renal function
metastasis
adjuvant chemotherapy
  • 2 views
  • 26 Jan, 2021
  • 1 location
Neoadjuvant Therapy in Biliary Adenocarcinoma

Feasibility of neoadjuvant therapy in resectable biliary adenocarcinoma.

  • 0 views
  • 31 Mar, 2021
  • 1 location